Jiali Li

Title: The Innovative Mind of Jiali Li: Pioneering Cancer Treatment Solutions

Introduction: Jiali Li, an accomplished inventor based in San Diego, CA, has made significant strides in the field of pharmaceutical innovation. With a focus on addressing breast cancer treatment, Jiali’s work holds promise for many patients affected by this disease, particularly those with specific genetic mutations.

Latest Patents: Jiali Li is credited with one notable patent entitled "Estrogen receptor modulators for treating mutants." This patent details the uses and methods of administering an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof. The innovation is especially geared towards treating breast cancer in subjects who display at least one point mutation within the Estrogen Receptor 1 (ESR1), which encodes the Estrogen receptor alpha (ERα). This targeted therapy presents a crucial advancement in personalized medicine.

Career Highlights: Jiali Li currently works at Recurium IP Holdings, LLC, where her expertise is pivotal in driving forward-thinking research and development in cancer therapeutics. Her dedication to enhancing treatment outcomes for breast cancer patients demonstrates her commitment to making a difference in the healthcare landscape.

Collaborations: Throughout her career, Jiali has collaborated with fellow researchers such as Ahmed Abdi Samatar and Jianhui Ma. These partnerships underscore her ability to work within a team of driven professionals, fostering an environment of innovation and shared knowledge.

Conclusion: Jiali Li's contributions to the field of cancer treatment through her innovative patent is a testament to her skill and dedication as an inventor. Her work not only enhances the knowledge base within pharmaceutical science but also offers hope for improved therapeutic options for patients battling breast cancer. As she continues to develop her career at Recurium IP Holdings, the future looks bright for her and the patients she seeks to help.